KaleidoUSA is the story of people, process and production. Together world recognized mycologists and formulists, proprietary science driven IP and formulations, high bioavailability organic compounds, multiple delivery methods plus world-class extraction technologies make KaleidoUSA a leader in the mycology space.

The production facility in Washington State already CBD licensed, will bring to market pressed pills, effervescents, muscle cream, anti-aging moisturizers, bath bombs and soaps as their first rollout to the consumer-markets globally. The team is already evaluating psilocybin and THC myco-dosing infused consumer packaged products initiatives with clinics in approved jurisdictions internationally. On January 13, 2021 Global Wellness Strategies Inc. announced that it had partnered with Clarion Holdings of Eugene, Oregon to open one of the first psilocybin consulting incubators in the area. KaleidoUSA will align itself directly with Clarion in Oregon and facilitate submission of a psilocybin license when available. KaleidoUSA will begin working with Canadian cannabis licensed producers and choose one LP to rollout a full medicinal-mushroom infused CBD product line into Canadian provincial government approved stores. European partners are already in discussions to begin marketing the CBD infused products in countries where approved.